5. Conclusion
Our findings demonstrate thata combination of adjuvant treatmentwith
HFCWO may help children withM. pneumoniae pneumonia to achieve clear improvements in clinical
symptoms, reduce the length of hospital stays, and reduce costs. Further
studies, incorporating multiple centers, are now needed to evaluate
clinical efficacy, tolerability, adverse effects, and cost
effectiveness.